Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Joel Marrs to Risk Factors

This is a "connection" page, showing publications Joel Marrs has written about Risk Factors.

 
Connection Strength
 
 
 
0.163
 
  1. Marrs JC, Kostoff MD. Discontinuation of Statins: What Are the Risks? Curr Atheroscler Rep. 2016 Jul; 18(7):41.
    View in: PubMed
    Score: 0.063
  2. Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7.
    View in: PubMed
    Score: 0.056
  3. Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R. Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894.
    View in: PubMed
    Score: 0.019
  4. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the acute management and secondary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e115-42.
    View in: PubMed
    Score: 0.012
  5. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e101-14.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)